EGR1 and osteosarcoma: In conclusion, ML264 inhibited the JAK2/STAT3 and Wnt/β‐catenin signalling pathways via down‐regulation of KLF5 and EGR1 expression, thereby inhibiting proliferation and metastasis of osteosarcoma cells (Figure 5G).